PBYI.NASDAQPuma Biotechnology, INC

SCHEDULE 13G/A: BlackRock Discloses 5.6% Passive Stake in Puma Biotechnology Inc.

Sentiment:

Beneficial Ownership Report

📋All filings for Puma Biotechnology, INC
🔒Login to Follow

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.6% beneficial ownership stake in Puma Biotechnology Inc. as of March 31, 2025.

Summary

  • BlackRock, Inc. reported beneficial ownership of 2,779,452 shares of Common Stock in Puma Biotechnology Inc.
  • This ownership represents 5.6% of the class of securities outstanding.
  • BlackRock holds sole voting power over 2,744,079 shares and sole dispositive power over 2,779,452 shares.
  • The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously reported passive investment.
  • BlackRock certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a passive ownership stake by a large institutional investor. It is neutral in tone but the presence of a significant institutional holder can be viewed positively by the market.

Stakeholder Impact

  • Shareholders: Provides transparency regarding significant institutional ownership, potentially signaling confidence from a major asset manager.

Key Dates

DateDescription
03/31/2025Date of event which requires filing of this statement (reporting period end date)
04/17/2025Date of signature for the Schedule 13G filing

Keywords

BlackRock, Puma Biotechnology Inc., Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, SEC Filing, Biotechnology

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.